Browse > Article
http://dx.doi.org/10.4014/jmb.1809.09028

Hepatitis E Virus Papain-Like Cysteine Protease Inhibits Type I Interferon Induction by Down-Regulating Melanoma Differentiation-Associated Gene 5  

Kim, Eunha (Korea Zoonosis Research Institute & Genetic Engineering Research Institute, Chonbuk National University)
Myoung, Jinjong (Korea Zoonosis Research Institute & Genetic Engineering Research Institute, Chonbuk National University)
Publication Information
Journal of Microbiology and Biotechnology / v.28, no.11, 2018 , pp. 1908-1915 More about this Journal
Abstract
Upon viral infection, the host cell recognizes the invasion through a number of pattern recognition receptors. Melanoma differentiation associated gene 5 (MDA5) and retinoic acid-inducible gene-I (RIG-I) recognize RNA molecules derived from invading viruses, activating down-stream signaling cascades, culminating in the induction of the type I interferon. On the other hand, viruses have evolved to evade type I interferon-mediated inhibition. Hepatitis E virus has been shown to encode a few antagonists of type I interferon and it is not surprising that viruses encode multiple mechanisms of viral evasion. In the present study, we demonstrated that HEV PCP strongly down-regulates MDA5-mediated activation of interferon ${\beta}$ induction in a dose-dependent manner. Interestingly, MDA5 protein expression was almost completely abolished. In addition, polyinosinic polycytidylic acid (poly(I:C))- and Sendai virus-mediated activation of type I interferon responses were similarly abrogated in the presence of HEV PCP. Furthermore, HEV PCP down-regulates several molecules that play critical roles in the induction of type I IFN expression. Taken together, these data collectively suggest that HEV-encoded PCP is a strong antagonist of type I interferon.
Keywords
Hepatitis E virus; type I interferon; interferon beta; MDA5;
Citations & Related Records
Times Cited By KSCI : 9  (Citation Analysis)
연도 인용수 순위
1 Forni D, Cagliani R, Clerici M, Sironi M. 2018. Origin and dispersal of Hepatitis E virus. Emerg. Microbes Infect. 7: 11.
2 Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120-131.   DOI
3 Kang S, Myoung J. 2017. Host innate immunity against Hepatitis E virus and viral evasion mechanisms. J. Microbiol. Biotechnol. 27: 1727-1735.   DOI
4 Kumar S, Subhadra S, Singh B, Panda BK. 2013. Hepatitis E virus: the current scenario. Int. J. Infect. Dis. 17: e228-233.   DOI
5 Krawczynski K. 1993. Hepatitis E. Hepatology 17: 932-941.   DOI
6 Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. 1980. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 2: 876-879.
7 Khuroo MS. 1980. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 68: 818-824.   DOI
8 Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, et al. 1 990. Isolation o f a cDNA f rom the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247: 1335-1339.   DOI
9 Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. 2007. Hepatitis E virus i nf ection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol. 22: 676-682.   DOI
10 Navaneethan U, Al Mohajer M, Shata MT. 2008. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28: 1190-1199.   DOI
11 Kang HS, Myoung J, So EY, Bahk YY, Kim BS. 2016. Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination. J. Neuroinflammation 13: 133.   DOI
12 Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. 2015. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15: 405-414.   DOI
13 Kim N, Now H, Nguyen NTH, Yoo JY. 2016. Multilayered regulations of RIG-I in the anti-viral signaling pathway. J. Microbiol. 54: 583-587.   DOI
14 Schmidt ME, Varga SM. 2017. Modulation of the host immune response by respiratory syncytial virus proteins. J. Microbiol. 55: 161-171.   DOI
15 Gillen J, Li W, Liang Q, Avey D, Wu J, Wu F, et al. 2015. A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses. J. Virol. 89: 4918-4931.   DOI
16 Ha S, Choi IS, Choi C, Myoung J. 2016. Infection models of human norovirus: challenges and recent progress. Arch. Virol. 161: 779-788.   DOI
17 Lee M, Seo DJ, Seo J, Oh H, Jeon SB, Ha SD, et al. 2015. Detection of viable murine norovirus using the plaque assay and propidium-monoazide-combined real-time reverse transcription-polymerase chain reaction. J. Virol. Methods 221: 57-61.   DOI
18 Karpe YA, Lole KS. 2011. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92: 2088-2092.   DOI
19 Oshiumi H, Miyashita M, Matsumoto M, Seya T. 2013. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9: e1003533.   DOI
20 Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.   DOI
21 Kang S, Myoung J. 2017. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J. Microbiol. 55: 319-329.   DOI
22 Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.   DOI
23 Kang S, Choi C, Choi I, Han KN, Roh SW, Choi J, et al. 2018. Hepatitis E virus methyltransferase inhibits type I interferon induction by targeting RIG-I. J. Microbiol. Biotechnol. doi: 10.4014/jmb.1808.08058 [Epub ahead of print]
24 Draenert R, Frater J, Prado JG. 2012. Virus immune evasion: new mechanism and implications in disease outcome. Adv. Virol. 2012: 490549.
25 Senba M, Mori N. 2012. Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev. 6(2): e17.   DOI
26 Uddin MB, Lee BH, Nikapitiya C, Kim JH, Kim TH, Lee HC, et al. 2016. Inhibitory effects of bee venom and its components against viruses in vitro and in vivo. J. Microbiol. 54: 853-866.   DOI
27 Nan Y, Yu Y, Ma Z, Khattar SK, Fredericksen B, Zhang YJ. 2014. Hepatitis E virus inhibits type I interferon induction by ORF1 products. J. Virol. 88: 11924-11932.   DOI
28 Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.   DOI
29 Surjit M, Varshney B, Lal SK. 2012. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-kappaB activity by blocking ubiquitination mediated proteasomal degradation of IkappaBalpha in human hepatoma cells. BMC Biochem. 13: 7.   DOI
30 Lee BH, Chathuranga K, Uddin MB, Weeratunga P, Kim MS, Cho WK, et al. 2017. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state. J. Microbiol. 55: 488-498.   DOI
31 Seong RK, Choi YK, Shin OS. 2016. MDA7/IL-24 is an antiviral factor that inhibits influenza virus replication. J. Microbiol. 54: 695-700.   DOI
32 Lai HC, Horng YT, Yeh PF, Wang JY, Shu CC, Lu CC, et al. 2016. The assessment of host and bacterial proteins in sputum from active pulmonary tuberculosis. J. Microbiol. 54: 761-767.   DOI
33 Weeratunga P, Uddin MB, Kim MS, Lee BH, Kim TH, Yoon JE, et al. 2016. Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components. J. Microbiol. 54: 57-70.   DOI
34 Weeratunga P, Herath TUB, Kim TH, Lee HC, Kim JH, Lee BH, et al. 2017. Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo. J. Microbiol. 55: 909-917.   DOI
35 Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345.   DOI
36 Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.   DOI
37 Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988.   DOI
38 Hamid FB, Kim J, Shin CG. 2017. Characterization of prototype foamy virus infectivity in transportin 3 knockdown human 293t cell line. J. Microbiol. Biotechnol. 27: 380-387.   DOI
39 He M, Wang M, Huang Y, Peng W, Zheng Z, Xia N, et al. 2016. The ORF3 protein of genotype 1 Hepatitis E virus suppresses TLR3-induced NF-kappaB signaling via TRADD and RIP1. Sci. Rep. 6: 27597.   DOI
40 Choi S, Park H, Minelko M, Kim EK, Cho MR, Nam JH. 2017. Recombinant adeno-associated virus expressing truncated IK cytokine diminishes the symptoms of inflammatory arthritis. J. Microbiol. Biotechnol. 27: 1892-1895.   DOI
41 Lee JM, Cho JB, Ahn HC, Jung W, Jeong YJ. 2017. A novel chemical compound for inhibition of SARS coronavirus helicase. J. Microbiol. Biotechnol. 27: 2070-2073.   DOI
42 Liu X, Dong Y, Wang J, Li L, Zhong Z, Li YP, et al. 2017. VSV-G viral envelope glycoprotein prepared from Pichia pastoris enhances transfection of DNA into animal cells. J Microbiol Biotechnol. 27: 1098-1105.
43 Ahn HS, Han SH, Kim YH, Park BJ, Kim DH, Lee JB, et al. 2017. Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus. Virology 512: 187-193.   DOI
44 Cho M, Myoung J. 2015. OX40 and 4-1BB downregulate Kaposi's sarcoma-associated herpesvirus replication in lymphatic endothelial cells, but 4-1BB and not OX40 inhibits viral replication in B-cells. J. Gen. Virol. 96: 3635-3645.   DOI
45 Fu B, Kuang E, Li W, Avey D, Li X, Turpin Z, et al. 2015. Activation of p90 ribosomal S6 kinases by ORF45 of Kaposi's sarcoma-associated herpesvirus is critical for optimal production of infectious viruses. J. Virol. 89: 195-207.   DOI
46 Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. 2015. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347: aaa2630.   DOI
47 Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.   DOI
48 Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.   DOI
49 Grandvaux N, Servant MJ, tenOever B, Sen GC, Balachandran S, Barber GN, et al. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76: 5532-5539.   DOI
50 Honda K, Takaoka A, Taniguchi T. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.   DOI